Covered recipient · General Payments record
JESSICA PILLOW
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,232.97
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $387.43 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $115.29 | 6 |
| UCB, Inc. | $91.47 | 3 |
| Amgen Inc. | $84.00 | 5 |
| ABBVIE INC. | $43.39 | 2 |
| GENZYME CORPORATION | $38.27 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.59 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105270143 | CMS |
| ABBVIE INC. | $28.80 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105270147 | CMS |
| Amgen Inc. | $15.89 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117354375 | CMS |
| Amgen Inc. | $13.86 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117354377 | CMS |
| Amgen Inc. | $20.60 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117354379 | CMS |
| Amgen Inc. | $15.81 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117354381 | CMS |
| Amgen Inc. | $17.84 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117354383 | CMS |
| GENZYME CORPORATION | $21.40 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139735500 | CMS |
| GENZYME CORPORATION | $16.87 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139735548 | CMS |
| Lilly USA, LLC | $20.07 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135021008 | CMS |
| Lilly USA, LLC | $17.47 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135021010 | CMS |
| Lilly USA, LLC | $20.07 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135021012 | CMS |
| Lilly USA, LLC | $17.47 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135062967 | CMS |
| Lilly USA, LLC | $23.42 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135065529 | CMS |
| Lilly USA, LLC | $16.79 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135065527 | CMS |
| Novartis Pharmaceuticals Corporation | $15.01 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087317043 | CMS |
| UCB, Inc. | $30.51 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143181222 | CMS |
| UCB, Inc. | $30.45 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143181226 | CMS |
| UCB, Inc. | $30.51 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143181230 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.